Davallou
Davallou v. Glenmark Pharmaceuticals US Head Quarters
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 10 HARRY H. DAVALLOU, Case No.: 20-cv-00619-DMS-MDD
Plaintiff,
ORDER GRANTING MOTION TO
v. DISMISS GLENMARK PHARMACEUTICALS US HEAD QUARTERS, a business of 15 unknown form, 16 Defendant. 17 18 Pending before the Court is Defendant Glenmark Pharmaceuticals Inc.’s motion to dismiss Plaintiff Harry H. Davallou’s Complaint for failure to state a claim. Plaintiff, proceeding pro se, filed two separate responses to Defendant’s motion, and Defendant filed a reply. For the reasons given herein, the Court grants Defendant’s motion to dismiss without prejudice. I. BACKGROUND On March 3, 2020, Plaintiff filed a Complaint based on products liability in the Superior Court of California, County of San Diego. (ECF No. 1 at 11). Plaintiff alleges that in November of 2019, his previously mild Parkinson’s disease worsened and he experienced “general weakness in [his]…